Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell C Benson

Showing results (81-90 of 136) with videos related to

Pageof 14
Sort By:
Clinical Genitourinary Cancer|November 9, 2017
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active SurveillanceMichael J Whalen, Jamie S Pak, Danny Lascano, et al.
Cancer Journal (Sudbury, Mass.)|June 21, 2002
Postprostatectomy salvage radiation therapy for prostate cancer: impact of pathological and biochemical variables and prostate fossa biopsyMarc R Mosbacher, Peter B Schiff, Kathleen M Otoole, et al.
Urology|November 10, 2007
Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA eraCarl K Gjertson, Kevin P Asher, Joshua D Sclar, et al.
Journal of Endourology|October 6, 2010
Contemporary experience in the management of angiomyolipomaAdam C Mues, Jorge Moreno Palacios, George Haramis, et al.
Urologic Oncology|July 8, 2014
Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancerScott M Stevenson, Matthew R Danzig, Rashed A Ghandour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapyJames M McKiernan, Puneet Masson, Alana M Murphy, et al.
Urology|October 18, 2011
Validating the use of the Mimic dV-trainer for robotic surgery skill acquisition among urology residentsRuslan Korets, Adam C Mues, Joseph A Graversen, et al.
BJU International|October 31, 2012
Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparisonChad R Ritch, Belinda F Morrison, Greg Hruby, et al.
Urologic Oncology|April 15, 2004
Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesiclesChristopher W Johnson, Aristotelis G Anastasiadis, James M McKiernan, et al.
Journal of the Society for Integrative Oncology|May 30, 2009
Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trialJillian L Capodice, Prakash Gorroochurn, A Sam Cammack, et al.
Pageof 14

Showing results (81-90 of 136) with videos related to

Sort By:
Pageof 14
Clinical Genitourinary Cancer|November 9, 2017
Oncologic Outcomes of Definitive Treatments for Low- and Intermediate-Risk Prostate Cancer After a Period of Active SurveillanceMichael J Whalen, Jamie S Pak, Danny Lascano, et al.
Cancer Journal (Sudbury, Mass.)|June 21, 2002
Postprostatectomy salvage radiation therapy for prostate cancer: impact of pathological and biochemical variables and prostate fossa biopsyMarc R Mosbacher, Peter B Schiff, Kathleen M Otoole, et al.
Urology|November 10, 2007
Local control and long-term disease-free survival for stage D1 (T2-T4N1-N2M0) prostate cancer after radical prostatectomy in the PSA eraCarl K Gjertson, Kevin P Asher, Joshua D Sclar, et al.
Journal of Endourology|October 6, 2010
Contemporary experience in the management of angiomyolipomaAdam C Mues, Jorge Moreno Palacios, George Haramis, et al.
Urologic Oncology|July 8, 2014
Cost-effectiveness of neoadjuvant chemotherapy before radical cystectomy for muscle-invasive bladder cancerScott M Stevenson, Matthew R Danzig, Rashed A Ghandour, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2006
Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapyJames M McKiernan, Puneet Masson, Alana M Murphy, et al.
Urology|October 18, 2011
Validating the use of the Mimic dV-trainer for robotic surgery skill acquisition among urology residentsRuslan Korets, Adam C Mues, Joseph A Graversen, et al.
BJU International|October 31, 2012
Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparisonChad R Ritch, Belinda F Morrison, Greg Hruby, et al.
Urologic Oncology|April 15, 2004
Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesiclesChristopher W Johnson, Aristotelis G Anastasiadis, James M McKiernan, et al.
Journal of the Society for Integrative Oncology|May 30, 2009
Zyflamend in men with high-grade prostatic intraepithelial neoplasia: results of a phase I clinical trialJillian L Capodice, Prakash Gorroochurn, A Sam Cammack, et al.
Pageof 14